Sales climb at Unilabs

Miguel Payro (left), investor relations director and Edgard Zwirn, CEO Unilabs Keystone

The Geneva-based company, Unilabs, has posted impressive results, with the latest figures showing sales up by nearly 15 per cent over the past financial year.

This content was published on July 12, 2000 - 13:20

The company announced sales growth of 14.8 per cent, with turnover reaching SFr162.9 million.

The company attributed the increase to strong demand in its target markets.

Unilabs is a European leader in the field of medical laboratory analysis, with 1,000 staff in five countries, and 30 laboratories.

Meanwhile, the company has announced a reshuffle at boardroom level. Cosimo Picci, formerly of Atag Ernst and Young, is to take over as financial director of the group. He will replace Bruno Adam, who will take responsibility for the group's operation in France and Italy.

swissinfo with agencies

Articles in this story

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?